IL16 and breast neoplasm: Furthermore, Il-16 (2.7-fold) and C-X-C motif chemokine ligand 9 (Cxcl9, ninefold) levels were significantly increased in SRC-3 KD E0771 breast tumors compared to control breast tumors (Fig. 10E, F).